METHOD OF TREATING LUNG CANCER IN EXPERIMENT Russian patent published in 2010 - IPC A61N2/00 

FIELD: medicine.

SUBSTANCE: invention refers to experimental oncology, and can be used for treating metastatic lung cancer by the combined electromagnetic exposure. A metastatic lung involvement is simulated. 1 week after the transplantation and within 5 weeks of the treatment, a magnetotherapy session is prescribed 4 times a week at 9-10 o'clock in the morning. The cerebrum is exposed to the very low-frequency magnetic fields in a discrete frequency sequence 0.03 Hz - 0.3 Hz - 9 Hz with appropriate exposure length 5 min - 1 min. - 1 min. and magnetic field induction 5 mT - 3.5 mT - 2.8 mT which is weekly reduced exponentially in a factor 0.7. 15-20 minutes later, SCENAR therapy session follows. Skin surfaces are treated with pulse electric current along the backbone at amplitude 135 standard units and a projection of the lungs, liver and breast at amplitude 30 to 60 standard units, with amplitude modulation 2:1 at daily frequency variation by the algorithm 15.3 Hz - 18.6 Hz - 24.4 Hz - 30.5 Hz - 33.6 Hz.

EFFECT: method allows improving an antistress, immunomodulating, energy stimulating, self-organising systemic exposure and enabling therapeutic anticancer effect without applying special cytostatic agents and ionising radiation.

2 tbl